Strategic validation leader with over 20 years of global experience managing GxP engineering,
equipment, facility and process validation programs within the pharmaceutical industries. Proven track record in designing and implementing comprehensive validation strategies aligned with global regulatory standards, supporting inspections, and fostering continuous improvement. Adept at leading cross-functional teams, developing validation policies, driving digital transformation initiatives, and ensuring compliance excellence across international sites. Known for strong decision-making, effective communication, and building high-performing teams
• Lead, coach and mentor a dynamic validation department, overseeing daily operations and managing a team of 15 SMEs and engineers while aligning activities with the Johnson & Johnson CREDO and leadership imperatives.
• Design and implement comprehensive validation programs (PPQ, media fills/APS, Sterilization, Cleaning Validation, CPV) to support the development and manufacturing processes of Clinical Trial Materials (CTM) and commercial products, ensuring adherence to regulatory requirements.
• Leads the site validation approach in alignment with Global J&J policies & CMC teams to design & develop the validation strategy for the entire Bern project portfolio ensuring continuous improvement consistent with established and evolving regulatory and company requirements.
• Maintain current knowledge of regulatory trends and industry advancements, utilizing this insight to keep validation practices up to date.
• Establish annual goals and objectives for the validation team that align with site priorities and financial frameworks, driving high-performance outcomes.
• Oversee the creation and maintenance of Site Validation Master Plans, ensuring that all necessary documentation is current and accessible throughout the product lifecycle.
• Lead investigations related to deviations with impact on validation, facilitating cross-functional root cause analysis to address and resolve technical product/process issues.
• Ensure development and deployment of highly specialized skills appropriate to the validation team to meet the needs of the site's product portfolio and strategy.
• Act as a subject matter expert during health authority inspections and audits, providing critical support to internal teams. Achieved compliance with zero findings during external audits (in the last 3 years).
· 2022-2024: EU GMP Annex 1 gap assessment and remediation: ensuring Bern's validation processes aligned with the updated regulations. Responsible for conducting first-line assessments, defining corrective actions, remediating gaps, and leading cross-functional teams to implement necessary updates, resulting in successful compliance and readiness for regulatory inspections
· 2023: Achieved regulatory approval from Swissmedic, ANVISA, and FDA for the Lentivirus CAR-T process at Janssen Vaccines Bern, with zero findings related to Validation, marking a significant milestone in product development and patients' treatment
· 2022: Successfully executed process validation (PPQ) for the Lentivirus CAR-T project, leading to the completion of the Biologics License Application (BLA) submission at Janssen Vaccines Bern
· 2015-2022: Instrumental in supporting various Commissioning & Qualification (C&Q) and CSV projects that advanced the VPAD viral and bacterial platforms, facilitating the transition from Clinical Trial Material (CTM) to commercial phase production at Janssen Vaccines Bern.
· 2013-2015, Eli Lilly, RABS Cartridge Filling Line - Global Insulin Cartridge Program: Led the implementation of a new Restricted Access Barrier System (RABS) Cartridge Filling Line for Eli Lilly in Sesto Fiorentino, as part of the Global Insulin Cartridge Program. Authoring of specific tasks such as IQ/OQ/PQ and Media Fills. This project resulted in italian heath authority authorization.
· 2012, Kedrion SpA: Project Leader for the Supply Chain Cold Shipment Validation Project, effectively coordinating logistical validation activities among cross-functional teams in Germany, Austria, and Hungary.
· 2011, Chiesi Farmaceutici Parma site, New Research Center Project: Successfully managed the validation process from commissioning to operational readiness for the new Research Center Project at Chiesi Farmaceutici in Parma, which received AIFA authorization.
· 2010/2011, Janssen Latina site (Italy), Technology Transfer Project: successfully performed validation activities for the Technology Transfer Project, ensuring compliance and efficacy of new QC laboratory equipment.
· 2009, Ely Lilly 6thOctober City site, New Egyptian Laboratory Project: Project Leader from commissioning phase to validation of QC laboratory equipment and plants. Egyptian Agency authorization granted.
2008/2009, Novartis V&D Rosia site, Automations Projects: Managed several automation projects at Novartis V&D Rosia, spearheading the CSV of systems such as Track and Trace and visual inspection manufacturing automation systems